Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects

Uterine carcinosarcoma (CS), leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) have historically been considered as main subtypes of uterine sarcomas (USs). Depending on the classification, 3% to 9% of malignancies of the uterine corpus and about 1% of all female genital tract malignancies...

Full description

Bibliographic Details
Main Author: Koivisto-Korander, Riitta
Other Authors: Grénman, Seija, University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos, Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin, Leminen, Arto
Format: Doctoral or Postdoctoral Thesis
Language:English
Published: Helsingin yliopisto 2012
Subjects:
Online Access:http://hdl.handle.net/10138/37096
id ftunivhelsihelda:oai:helda.helsinki.fi:10138/37096
record_format openpolar
spelling ftunivhelsihelda:oai:helda.helsinki.fi:10138/37096 2023-08-20T04:07:33+02:00 Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects Koivisto-Korander, Riitta Grénman, Seija University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin Leminen, Arto 2012-10-05T07:35:43Z application/pdf http://hdl.handle.net/10138/37096 eng eng Helsingin yliopisto Helsingfors universitet University of Helsinki URN:ISBN:978-952-10-8278-8 Helsinki: Unigrafia, 2012 http://hdl.handle.net/10138/37096 URN:ISBN:978-952-10-8279-5 Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty. This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited. Publikationen är skyddad av upphovsrätten. Den får läsas och skrivas ut för personligt bruk. Användning i kommersiellt syfte är förbjuden. naistentaudit ja synnytykset gynekologinen onkologia Text Doctoral dissertation (article-based) Artikkeliväitöskirja Artikelavhandling doctoralThesis 2012 ftunivhelsihelda 2023-07-28T06:24:37Z Uterine carcinosarcoma (CS), leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) have historically been considered as main subtypes of uterine sarcomas (USs). Depending on the classification, 3% to 9% of malignancies of the uterine corpus and about 1% of all female genital tract malignancies are USs. However, it has been estimated that USs account for nearly one third of deaths from uterine malignancies. The aims of these studies were to assess clinical behavior, survival, prognostic markers and epidemiological aspects of uterine CS, LMS and ESS. In a retrospective study we analyzed survival and prognostic markers (both clinical and immunohistochemical) in patients treated from 1990 to 2001 at Helsinki University Central Hospital (HUCH). In the epidemiological studies the incidence and occupational risk of uterine LMS and ESS were examined by using the NORDCAN and Nordic Occupational Cancer Study (NOCCA) databases. A cohort of 8606 cases of USs from 13 cancer registries was used to evaluate the risk of a second primary malignancy after the first primary US. This study was co-ordinated by the International Agency for Research on Cancer (IARC). The age-adjusted incidence of LMS was about 0.4 0.5 per 100 000 and that of ESS about 0.2 per 100 000 in Iceland, Denmark, Finland and Norway during the study period 1978 2007. Age-specific incidences were highest around menopause for both subtypes of USs. Shoe and leather workers, farmers and teachers showed elevated standardized incidence ratios (SIRs) as regards LMS. However, no occupations were associated with increased SIRs in connection with ESS. One hundred patients with uterine CS (n = 40), LMS (n = 39) and ESS (n = 21) were treated in our institution during 1990 2001. The 2-, 5-, and 10-year disease-specific survival rates were 64%, 56% and 38% for all subtypes grouped together and 5-year survival rates for each subtype separately were 49% (CS), 57% (LMS) and 65% (ESS). Stage, age, tumor size and delivery status were independently associated with survival ... Doctoral or Postdoctoral Thesis Iceland Helsingfors Universitet: HELDA – Helsingin yliopiston digitaalinen arkisto Norway
institution Open Polar
collection Helsingfors Universitet: HELDA – Helsingin yliopiston digitaalinen arkisto
op_collection_id ftunivhelsihelda
language English
topic naistentaudit ja synnytykset
gynekologinen onkologia
spellingShingle naistentaudit ja synnytykset
gynekologinen onkologia
Koivisto-Korander, Riitta
Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects
topic_facet naistentaudit ja synnytykset
gynekologinen onkologia
description Uterine carcinosarcoma (CS), leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) have historically been considered as main subtypes of uterine sarcomas (USs). Depending on the classification, 3% to 9% of malignancies of the uterine corpus and about 1% of all female genital tract malignancies are USs. However, it has been estimated that USs account for nearly one third of deaths from uterine malignancies. The aims of these studies were to assess clinical behavior, survival, prognostic markers and epidemiological aspects of uterine CS, LMS and ESS. In a retrospective study we analyzed survival and prognostic markers (both clinical and immunohistochemical) in patients treated from 1990 to 2001 at Helsinki University Central Hospital (HUCH). In the epidemiological studies the incidence and occupational risk of uterine LMS and ESS were examined by using the NORDCAN and Nordic Occupational Cancer Study (NOCCA) databases. A cohort of 8606 cases of USs from 13 cancer registries was used to evaluate the risk of a second primary malignancy after the first primary US. This study was co-ordinated by the International Agency for Research on Cancer (IARC). The age-adjusted incidence of LMS was about 0.4 0.5 per 100 000 and that of ESS about 0.2 per 100 000 in Iceland, Denmark, Finland and Norway during the study period 1978 2007. Age-specific incidences were highest around menopause for both subtypes of USs. Shoe and leather workers, farmers and teachers showed elevated standardized incidence ratios (SIRs) as regards LMS. However, no occupations were associated with increased SIRs in connection with ESS. One hundred patients with uterine CS (n = 40), LMS (n = 39) and ESS (n = 21) were treated in our institution during 1990 2001. The 2-, 5-, and 10-year disease-specific survival rates were 64%, 56% and 38% for all subtypes grouped together and 5-year survival rates for each subtype separately were 49% (CS), 57% (LMS) and 65% (ESS). Stage, age, tumor size and delivery status were independently associated with survival ...
author2 Grénman, Seija
University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine
Helsingin yliopisto, lääketieteellinen tiedekunta, kliininen laitos
Helsingfors universitet, medicinska fakulteten, institutionen för klinisk medicin
Leminen, Arto
format Doctoral or Postdoctoral Thesis
author Koivisto-Korander, Riitta
author_facet Koivisto-Korander, Riitta
author_sort Koivisto-Korander, Riitta
title Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects
title_short Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects
title_full Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects
title_fullStr Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects
title_full_unstemmed Uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : Epidemiological, clinical and prognostic aspects
title_sort uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma : epidemiological, clinical and prognostic aspects
publisher Helsingin yliopisto
publishDate 2012
url http://hdl.handle.net/10138/37096
geographic Norway
geographic_facet Norway
genre Iceland
genre_facet Iceland
op_relation URN:ISBN:978-952-10-8278-8
Helsinki: Unigrafia, 2012
http://hdl.handle.net/10138/37096
URN:ISBN:978-952-10-8279-5
op_rights Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Publikationen är skyddad av upphovsrätten. Den får läsas och skrivas ut för personligt bruk. Användning i kommersiellt syfte är förbjuden.
_version_ 1774719238311772160